Nephros, Inc. (NEPH) Prices 937.5K Share Common Offering at $8/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Nephros Announces Pricing of $7.5 Million Underwritten Offering of Common Stock
January 31, 2020 7:30 AM ESTSOUTH ORANGE, NJ, Jan. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE Nephros, Inc. (Nasdaq: NEPH) (Nephros or the Company), a  commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical device and commercial markets, today announced the pricing of a firm commitment underwritten offering of 937,500 shares of common stock at a price to the public of $8.00 per share for aggregate gross proceeds of approximately $7,500,000, before underwriting discounts and offering expenses. The offering is expected to close on or about February 4, 2020, subject to the satisfaction of customary closing conditions.
... More


